INTELLIGENT ULTRASOUND GROUP PLC Intelligent Ultrasound Group plc Share Price
Equities
MED
GB00BN791Q39
Professional & Business Education
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 8.85 GBX | -3.80% |
|
+4.12% | -5.35% |
| 04-19 | Intelligent Ultrasound launches GE AI software on ultrasound machines | AN |
| 04-19 | Sonolyst Launched on Voluson Signature Series | CI |
| Sales 2023 * | 11.2M 13.99M 1.12B | Sales 2024 * | 15.6M 19.49M 1.56B | Capitalization | 28.93M 36.14M 2.89B |
|---|---|---|---|---|---|
| Net income 2023 * | -3M -3.75M -300M | Net income 2024 * | - | EV / Sales 2023 * | 2.31 x |
| Net cash position 2023 * | 3M 3.75M 300M | Net cash position 2024 * | 2.5M 3.12M 250M | EV / Sales 2024 * | 1.69 x |
| P/E ratio 2023 * |
-9.83
x | P/E ratio 2024 * |
-
| Employees | 65 |
| Yield 2023 * |
-
| Yield 2024 * |
-
| Free-Float | 88.71% |
More Fundamentals
* Assessed data
More news
More press releases
| 1 day | -3.80% | ||
| 1 week | +4.12% | ||
| Current month | -6.84% | ||
| 1 month | -9.23% | ||
| 3 months | +2.61% | ||
| 6 months | -6.84% | ||
| Current year | -5.35% |
1 week
8.50
9.50
1 month
8.3410.00
Current year
7.5311.50
1 year
7.5316.67
3 years
6.2520.01
5 years
4.8020.60
10 years
4.8060.00
| Managers | Title | Age | Since |
|---|---|---|---|
Stuart Gall
CEO | Chief Executive Officer | 62 | - |
Helen Jones
DFI | Director of Finance/CFO | - | 31/12/19 |
Kathryn Jenner
CTO | Chief Tech/Sci/R&D Officer | - | 31/08/15 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
| Chairman | 77 | 31/12/11 | |
Stuart Gall
CEO | Chief Executive Officer | 62 | - |
| Director/Board Member | 40 | 18/05/21 |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26/04/24 | 8.85 | -3.80% | 30,109 |
| 25/04/24 | 9.2 | +5.14% | 208,921 |
| 24/04/24 | 8.75 | +2.94% | 109,837 |
| 23/04/24 | 8.5 | -5.56% | 104,427 |
| 22/04/24 | 9 | +5.88% | 130,696 |
Delayed Quote London S.E., April 26, 2024 at 04:35 pm
More quotes
Intelligent Ultrasound Group plc is an ultrasound company, specialized in artificial intelligence (AI) software and simulation. The Company specializes in real-time hi-fidelity virtual reality simulation for the ultrasound training market (classroom) and AI-based clinical image analysis software tools for the diagnostic medical ultrasound market (clinic). The Company's Simulation segment offers various products that includes ScanTrainer obstetrics and gynecology training simulator, the HeartWorks echocardiography training simulator, the BodyWorks Eve Point of Care and Emergency Medicine training simulator with Covid-19 module and the new BabyWorks Neonate and Pediatric training simulator. Its Clinical AI segment offers ScanNav ultrasound image analysis technology. Its products that utilize this technology are GE HealthCare's SonoLyst software; ScanNav Anatomy PNB that simplifies ultrasound image interpretation; and NeedleTrainer that teaches real-time ultrasound-guided needling.
Calendar
01/05/2024
- Q4 2023 Earnings Release
Trading Rating
Investor Rating
ESG Refinitiv
EPS Revisions
Annual profits - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| -5.35% | 36.03M | |
| -20.52% | 2.89B | |
| -37.25% | 2.18B | |
| +28.93% | 1.75B | |
| -18.19% | 1.61B | |
| +39.56% | 877M | |
| +17.55% | 837M | |
| -.--% | 813M | |
| +21.41% | 817M | |
| -1.11% | 797M |
- Stock Market
- Equities
- MED Stock
